GENE ONLINE|News &
Opinion
Blog

Oncology
China’s Hansoh Teams Up with Middle East Onco-Collaborator
2022-01-02
BeiGene launches IPO on Shanghai’s STAR market to raise $3B
2021-12-03
Acrivon Therapeutics to Advance Proteomics Platform & Oncology Pipeline with $100M Series B Financing
2021-11-12
2021 CSCO Highlights: JW Therapeutics, Innovent, Ambrx, HUTCHMED Release Latest Data on Cancer Drugs
2021-10-07
858 Therapeutics Launches with $60 Million Series A for Advancing Small-Molecule Drugs
2021-09-23
Poseida Presents Encouraging Preliminary Data for Autologous CAR-T Candidate Against Solid Tumors
2021-08-31
Merck Fortifies Oncology Pipeline with FDA Win for HIF-2α Inhibitor, Welireg
2021-08-17
Bayer Spends $2 Billion to Acquire a Startup on the Brink of an IPO
2021-08-05
Zai Lab, Schrödinger Collaborate to Advance Cancer Program
2021-08-05
China’s BeiGene to Build a Biologics Manufacturing Site in the US
2021-08-04
Innovent, Lilly Bag Third Approval for PD-1 Inhibitor Tyvyt in China
2021-06-07
Screening for a brighter future: NHS Oncology Virtual Conference
2021-05-28
BMS Wins Agenus’ anti-TIGIT Asset to Bolster I-O Pipeline
2021-05-21
Illumina Looks to Consolidate NGS Market in APAC Region, Collaborates with Geneseeq to Develop IVD Kits in China
2021-03-21
After Five Year Oncology Alliance, Takeda Acquires Maverick to Embark on Solid Tumor Quest
2021-03-10
1 2 3 4
LATEST
Biotech Showcase 2022: Healing the Psyche with Psychedelia
2022-01-17
Sex Dimorphism in Obesity and the Impact of Estrogen Hormone Therapy on Cardiometabolic Health
2022-01-17
ARM 2022: Industry Briefs on Cell and Gene Therapies
2022-01-17
Study Reveals a Form of Four-Stranded DNA that Links Protein Deficiency and Premature Aging
2022-01-17
Shanghai’s Everest Medicines Licenses Covid-19 Oral Antivirals from Singapore’s National Drug Discovery Platform
2022-01-17
Digital Health Programme to Connect British and Taiwanese Leaders
2022-01-17
Pfizer: Pneumonia Shot Can Be Given with COVID-19 Vaccine in Older Adults
2022-01-16
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!